MedTrace Logo

Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors

NCT06587022 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors.

Conditions

  • Spinal Tumor

Interventions

RADIATION

Target volume delineation

Group 1(small target delineation)：The target bolume only includes local tumor. Group 2(small target delineation)：The target bolume includes local tumor and adjacent vertebral area.

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Hongqing Zhuang · Peking University Third Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2026-12-30
Completion
2027-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06587022 on ClinicalTrials.gov